多中心研究胆汁动脉的早期预测结果
Maria Hukkinen1, Björn Fischler2, Ulrika Liliemark2
1Section of Pediatric Surgery and Pediatric Liver and Gut Research Group, New Children's Hospital, University of Helsinki and Helsinki University Hospital, Finland; ERN Rare-Liver, France.
Journal of pediatric surgery
|June 9, 2025
概括
酸氨基转移酶与血小板比率指数 (APRI) 在预测胆道缩 (BA) 结果方面并不优于AST. 胆管缩椎形 (BASM) 显著预测本地肝脏存活时间更短,即使在患者实现黄清除的情况下.
科学领域:
- 儿科肝病学 儿科肝病学
- 外科胃肠道外科手术
- 新生儿手术 新生儿手术
背景情况:
- 胆管缩 (BA) 是一种严重的新生儿肝病,需要迅速的手术干预.
- 预测 portoenterostomy 后的结果对于患者的管理和预后至关重要.
- 肝脏生物化学,APRI和患者特征是潜在的预后指标.
研究的目的:
- 为了比较肝脏生物化学,APRI和患者特征的预测值,以在移植肠道切除术时对BA结果进行比较.
- 分析黄清除和本地肝脏存活率的预测因素.
主要方法:
- 追溯观察性研究涉及七个三级中心.
- 使用后勤和考克斯回归分析黄清除 (COJ) 和本源肝存活 (NLS) 的预测因子.
- 基于细胞巨乳病毒检测的CMV相关BA的定义.
主要成果:
- 在630名患者中,58%的患者实现了COJ.
- 肝硬化缺失,CMV感染, portoenterostomy时年龄<60天,以及较低的AST/APRI预测COJ.
- COJ,胆道缩脏形 (BASM) 和肠静脉移植年龄>60天预测移植/死亡.
- 在COJ患者中,BASM预测了移植/死亡.
结论:
- 在预测BA结果方面,APRI并不优于AST.
- 在获得COJ的患者中,AST和APRI与NLS无关.
- BASM是较短NLS的强有力的预测因素,尽管 portoenterostomy年龄较小,COJ率相似.
- 在CMV阳性患者中,COJ可以在COJ后具有类似NLS的CMV阳性患者中实现.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...